These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7827760)

  • 41. [Alpha 1-antitrypsin deficiency and emphysema. Replacement therapy?].
    Johansen S; Gulsvik A
    Tidsskr Nor Laegeforen; 1989 Aug; 109(22):2142-5. PubMed ID: 2788939
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Expert statement for augmentation therapy in patients with alpha-1 antitrypsin deficiency].
    Köhnlein T; Schmidt-Scherzer K; Greulich T; Bals R
    Pneumologie; 2014 Jul; 68(7):492-5. PubMed ID: 25006842
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-density lipoproteins potentiate α1-antitrypsin therapy in elastase-induced pulmonary emphysema.
    Moreno JA; Ortega-Gomez A; Rubio-Navarro A; Louedec L; Ho-Tin-Noé B; Caligiuri G; Nicoletti A; Levoye A; Plantier L; Meilhac O
    Am J Respir Cell Mol Biol; 2014 Oct; 51(4):536-49. PubMed ID: 24787644
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Emphysema connected with Alpha-1 anti-trypsin deficiency].
    Olesiejuk R; Danielak-Rybka K; Wojnarowicz-Dmitruk B
    Pneumonol Alergol Pol; 2003; 71(7-8):344-8. PubMed ID: 15052968
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biochemical efficacy and safety of monthly augmentation therapy for alpha 1-antitrypsin deficiency.
    Hubbard RC; Sellers S; Czerski D; Stephens L; Crystal RG
    JAMA; 1988 Sep; 260(9):1259-64. PubMed ID: 3261353
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravenous human plasma-derived augmentation therapy in alpha 1-antitrypsin deficiency: from pharmacokinetic analysis to individualizing therapy.
    Zamora NP; Pla RV; Del Rio PG; Margaleff RJ; Frias FR; Ronsano JB
    Ann Pharmacother; 2008 May; 42(5):640-6. PubMed ID: 18413692
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CT of emphysema.
    Newell JD
    Radiol Clin North Am; 2002 Jan; 40(1):31-42, vii. PubMed ID: 11813818
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alpha-1-antitrypsin deficiency: optimal therapeutic regimen based on population pharmacokinetics.
    Soy D; de la Roza C; Lara B; Esquinas C; Torres A; Miravitlles M
    Thorax; 2006 Dec; 61(12):1059-64. PubMed ID: 16928711
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Long-term therapy of alpha 1-antitrypsin-deficiency-associated pulmonary emphysema with human alpha 1-antitrypsin].
    Wencker M; Banik N; Buhl R; Seidel R; Konietzko N
    Pneumologie; 1998 Oct; 52(10):545-52. PubMed ID: 9847632
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE).
    McElvaney NG; Burdon J; Holmes M; Glanville A; Wark PA; Thompson PJ; Hernandez P; Chlumsky J; Teschler H; Ficker JH; Seersholm N; Altraja A; Mäkitaro R; Chorostowska-Wynimko J; Sanak M; Stoicescu PI; Piitulainen E; Vit O; Wencker M; Tortorici MA; Fries M; Edelman JM; Chapman KR;
    Lancet Respir Med; 2017 Jan; 5(1):51-60. PubMed ID: 27916480
    [TBL] [Abstract][Full Text] [Related]  

  • 51. alpha1-Antitrypsin deficiency: best clinical practice.
    Kalsheker NA
    J Clin Pathol; 2009 Oct; 62(10):865-9. PubMed ID: 19783716
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of augmentation therapy in alpha-1 antitrypsin deficiency.
    Kueppers F
    Curr Med Res Opin; 2011 Mar; 27(3):579-88. PubMed ID: 21226542
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Replacement therapy for hereditary alpha1-antitrypsin deficiency. A program for long-term administration.
    Barker AF; Siemsen F; Pasley D; D'Silva R; Buist AS
    Chest; 1994 May; 105(5):1406-10. PubMed ID: 8181327
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Advances in Identifying Urine/Serum Biomarkers in Alpha-1 Antitrypsin Deficiency for More Personalized Future Treatment Strategies.
    Ferrarotti I; Corsico AG; Stolk J; Ottaviani S; Fumagalli M; Janciauskiene S; Iadarola P
    COPD; 2017 Feb; 14(1):56-65. PubMed ID: 27827549
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pulmonary Emphysema in a Child With Alpha-1 Antitrypsin Deficiency: Evaluation of 2 Years of Intravenous Augmentation Therapy.
    Esteves Brandão M; Conde B; Seixas S; Clotilde Silva J; Fernandes A
    Arch Bronconeumol (Engl Ed); 2019 Sep; 55(9):502-504. PubMed ID: 30871819
    [No Abstract]   [Full Text] [Related]  

  • 56. Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update.
    Casas F; Blanco I; Martínez MT; Bustamante A; Miravitlles M; Cadenas S; Hernández JM; Lázaro L; Rodríguez E; Rodríguez-Frías F; Torres M; Lara B
    Arch Bronconeumol; 2015 Apr; 51(4):185-92. PubMed ID: 25027067
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ).
    Hill AT; Campbell EJ; Bayley DL; Hill SL; Stockley RA
    Am J Respir Crit Care Med; 1999 Dec; 160(6):1968-75. PubMed ID: 10588615
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alpha-1 antitrypsin augmentation therapy.
    Wewers MD; Crystal RG
    COPD; 2013 Mar; 10 Suppl 1():64-7. PubMed ID: 23527997
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improving diagnosis and management of alpha-1 antitrypsin deficiency in primary care: translating knowledge into action.
    Fromer L
    COPD; 2010 Jun; 7(3):192-8. PubMed ID: 20486818
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alpha 1-antitrypsin augmentation therapy.
    Sandhaus RA
    Agents Actions Suppl; 1993; 42():97-102. PubMed ID: 8356934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.